Big Arrival in the Heart of Cardiology
Forget the typical fluff of appointments and good-byes; NYU Langone Health is stepping up its game with the appointment of Dr. Sunil Rao as the new director of the Leon H. Charney Division of Cardiology and Dr. Susheel Kodali to lead Interventional Cardiology. Rao fills the shoes of Glenn I. Fishman, a guy who’s not just an old hand in this field but shaped it over 25 years. Such moves can tip the scales on how we see healthcare innovation playing out in real time.
The Rao Reign Begins
Dr. Rao isn’t some rookie being thrown into the deep end. He’s internationally recognized, having brought new approaches to treating complex cardiovascular conditions. Oversight of clinical care, research, and education at the nation’s No. 1 ranked cardiology program is no small feat but fits him like a glove. Kudos to Fishman—he left some big sneakers to fill, yet Rao’s vision of advancing patient care gets him in the race. His work in interventional cardiology is a key bullet point: we’re talking innovation flowing into better patient outcomes. And let’s face it, who doesn’t like the sound of enhanced treatments, especially when it means less time eking out a hospital stay?
"Dr. Rao has played a central role in strengthening our Interventional Cardiology Program and advancing innovative approaches to patient care," says Alec C. Kimmelman, CEO of NYU Langone Health.
Kodali Steps Up
Enter Dr. Kodali, a whiz in structural heart disease and minimally invasive therapies, coming from Columbia's top-notch Structural Heart and Valve Center. Now, he’s taking up the baton at NYU Langone’s Cardiac Catheterization Laboratory. His history—with chart-topping advances like transcatheter aortic valve replacement, or TAVR—proves that he's a lynchpin for a new era of cardiovascular care. The shift here is about opening access to cutting-edge treatments. At the end of the day, this is precisely what can set patients—and the institution—on a course to win.
Transition With a Legacy in Mind
While Rao and Kodali are no strangers in the field, don’t underestimate the impact of Glenn I. Fishman stepping down. His era saw the division grow to over 300 faculty members with a wide span of expertise, backed by an eye-watering $800 million in grant funding. Education and mentorship from Fishman will continue, though. Mentor a few decades' worth of fledgling cardiologists and you see why the man’s influence matters.
Looking Forward: The Bigger Picture
Dr. Kodali and Rao both join careers entrenched in research and implementation of life-saving procedures, and that’s critical. NYU Langone is hanging onto its narrative for delivering excellent cardiovascular care, thanks to institutions that support high-risk and high-reward strategies. Clearly, Langone’s not just resting on its laurels—they're reinforcing them.
For an institution with a century-long legacy, their commitment to innovation and patient care reveals what future-forward medicine might look like. It paves the way for others stepping behind these leaders—with teaching methods poised to address emerging challenges in cardiovascular medicine.
Ultimately, this shuffle isn’t merely about swapping names on office doors. It's about setting benchmarks for global institutions, merging steadfast science with evolving technology, and, perhaps most crucially, staying ahead of the curve in providing first-rate patient care.
